4 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
Follow LY 353381: new trials by email Literature Review of LY 353381 trials Research Report on LY 353381
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis Arzoxifene, Raloxifene - Osteoporosis, Postmenopausal | Phase 3 | Completed | Eli Lilly and Company | 320 | 2006-10-01 | 2010-01-28 |
| Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer Arzoxifene, Placebo - Osteoporosis, Postmenopausal | Phase 3 | Completed | Eli Lilly and Company | 9369 | 2004-06-01 | 2010-06-02 |
| Effects of Arzoxifene on Bone Mass and the Uterus Arzoxifene, Placebo - Postmenopausal Bone Loss | Phase 3 | Completed | Eli Lilly and Company | 300 | 2004-04-01 | 2007-03-09 |
| Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer. LY353381, tamoxifen - Breast Neoplasms | Phase 3 | Completed | Eli Lilly and Company | 2006-07-19 |
Osteoporosis, Postmenopausal (3) · Breast Neoplasms (1) · Neoplasms (1)
United States (4) · Argentina (2) · Australia (1) · Canada (1) · Chile (1) · France (1) · India (1) · Italy (1) · Mexico (1) · Spain (1) · Taiwan (1)